Changes in copper and zinc status and response to dietary copper deficiency in metallothionein-overexpressing transgenic mouse heart

Journal of Nutritional Biochemistry

Volumn 18, Issue 11, 2007, Pages 714-718

  Kang, Y James ^a   Jiang, Youchun ^a   Saari, Jack T ^b  

^a University of Louisville School of Medicine   (United States)

^b Nutrition Research Center   (United States)

Author keywords

Copper; Heart hypertrophy; Metallothionein; Transgenic mice; Zinc

Indexed keywords

CERULOPLASMIN; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; IRON; MANGANESE SUPEROXIDE DISMUTASE; METALLOTHIONEIN; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; DIET RESTRICTION; HEART HYPERTROPHY; HEART PROTECTION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PUP (RODENT); STATISTICAL ANALYSIS; TRANSGENIC MOUSE; WEANING; WILD TYPE;

ANIMALS; CARDIOMEGALY; COPPER; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MYOCARDIUM; ZINC;

MUS; MUS MUSCULUS;

EID: 35348953339     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.10.009     Document Type: Article

References (27)

1. Elsherif L., Ortines R.V., Saari J.T., and Kang Y.J. Congestive heart failure in copper-deficient mice. Exp Biol Med 228 (2003) 811-817
2. Elsherif L., Wang L.P., Saari J.T., and Kang Y.J. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J Nutr 134 (2004) 855-860
3. Kang Y.J., Wu H., and Saari J.T. Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart. Proc Soc Exp Biol Med 223 (2000) 282-287
4. Kang Y.J., Zhou Z.X., Wu H., Wang G.W., Saari J.T., and Klein J.B. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80 (2000) 745-757
5. Davis S.R., and Cousins R.J. Metallothionein expression in animals: a physiological perspective on function. J Nutr 130 (2000) 1085-1088
6. Kagi J.H. Overview of metallothionein. Methods Enzymol 205 (1991) 613-626
7. Shaw C.F., Savas M.M., and Petering D.H. Ligand substitution and sulfhydryl reactivity of metallothionein. Methods Enzymol 205 (1991) 401-414
8. Kang Y.J., Chen Y., Yu A., Voss-McCowan M., and Epstein P.N. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100 (1997) 1501-1506
9. Reeves P.G., Nielsen F.H., and Fahey G.C. AIN-93 purified diets for laboratory rodents - final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 123 (1993) 1939-1951
10. Nielsen F.H., Zimmerman T.J., and Shuler T.R. Interactions among nickel, copper, and iron in rats - Liver and plasma content of lipids and trace-elements. Biol Trace Elem Res 4 (1982) 125-143
11. Sunderman Jr. F.W., and Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 16 (1970) 903-910
12. Spitz D.R., and Oberley L.W. An assay for superoxide-dismutase activity in mammalian tissue-homogenates. Anal Biochem 179 (1989) 8-18
13. Eaton D.L., and Cherian M.G. Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. Methods Enzymol 205 (1991) 83-88
14. Maret W. Oxidative metal release from metallothionein via zinc thiol-disulfide interchange. Proc Natl Acad Sci U S A 91 (1994) 237-241
15. Maret W. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem Int 27 (1995) 111-117
16. Kang Y.J. Metallothionein redox cycle and function. Exp Biol Med 231 (2006) 1459-1467
17. Chen Y., Saari J.T., and Kang Y.J. Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radic Biol Med 17 (1994) 529-536
18. Saari J.T. Chronic treatment with dimethyl-sulfoxide protects against cardiovascular defects of copper deficiency. Proc Soc Exp Biol Med 190 (1989) 121-124
19. Medeiros D.M., and Wildman R.E. Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc Soc Exp Biol Med 215 (1997) 299-313
20. Saari J.T. Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration. Can J Physiol Pharm 78 (2000) 848-855
21. Thomas J.P., Bachowski G.J., and Girotti A.W. Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochim Biophys Acta 884 (1986) 448-461
22. Chvapil M., Ryan J.N., and Zukoski C.F. Effect of zinc on lipid peroxidation in liver microsomes and mitochondria. Proc Soc Exp Biol Med 141 (1972) 150-153
23. Coppen D.E., Richardson D.E., and Cousins R.J. Zinc suppression of free radicals induced in cultures of rat hepatocytes by iron, t-butyl hydroperoxide, and 3-methylindole. Proc Soc Exp Biol Med 189 (1988) 100-109
24. Klaassen C.D., Choudhuri S., McKim Jr. J.M., Lehman-McKeeman L.D., and Kershaw W.C. In-vitro and in-vivo studies on the degradation of metallothionein. Environ Health Perspect 102 Suppl 3 (1994) 141-146
25. Puntarulo S. Iron, oxidative stress and human health. Mol Aspects Med 26 (2005) 299-312
26. Halliwell B., and Gutteridge J.M. Oxygen-toxicity, oxygen radicals, transition-metals and disease. Biochem J 219 (1984) 1-14
27. Kruszewski M. The role of labile iron pool in cardiovascular diseases. Acta Biochim Pol 51 (2004) 471-480